{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06452316",
            "orgStudyIdInfo": {
                "id": "CSB-C23-001"
            },
            "organization": {
                "fullName": "Claris Biotherapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency",
            "officialTitle": "A Single-Arm Open-Label Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-to-evaluate-the-safety-and-efficacy-of-csb-ophthalmic-solution-in-subjects-with-limbal-stem-cell-deficiency"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-05",
            "studyFirstSubmitQcDate": "2024-06-05",
            "studyFirstPostDateStruct": {
                "date": "2024-06-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Claris Biotherapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will enroll subjects with qualifying limbal stem cell deficiency (LSCD). All subjects will receive CSB-001 investigational drug in either one or both study eyes. The study is comprised of two identical phases (Dosing Phase I and II) of test article dosing separated by a 31- to 40-day period, the Dosing Holiday, where no test article is administered. Dosing Phase II is followed by an observational, noninterventional phase (Observation Phase)."
        },
        "conditionsModule": {
            "conditions": [
                "Limbal Stem Cell Deficiency"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CSB-001",
                    "type": "EXPERIMENTAL",
                    "description": "One drop CSB-001 twice daily for two 8-week dosing periods in the study eye(s)",
                    "interventionNames": [
                        "Biological: CSB-001 Ophthalmic Solution 0.1%"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "CSB-001 Ophthalmic Solution 0.1%",
                    "description": "CSB-001: human recombinant dHGF (5-amino acid deleted hepatocyte growth factor)",
                    "armGroupLabels": [
                        "CSB-001"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety as Assessed by Adverse Event Reporting",
                    "description": "Incidence of ocular and systemic adverse events",
                    "timeFrame": "Day 0 through Week 48"
                },
                {
                    "measure": "Safety as Assessed by Slit-lamp Biomicroscopy",
                    "description": "Change from baseline in slit-lamp parameters",
                    "timeFrame": "Day 0 through Week 48"
                },
                {
                    "measure": "Safety as Assessed by Best-corrected Distance LogMAR Visual Acuity",
                    "description": "Change from baseline using the Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart",
                    "timeFrame": "Day 0 through Week 48"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Efficacy as Assessed by Change in Stage of LSCD",
                    "description": "Change from baseline in LSCD signs based on imaging (white light, blue light with fluorescein and Wratten filter, and AS-OCT)",
                    "timeFrame": "Day 0 through Week 48"
                },
                {
                    "measure": "Efficacy as Assessed by Change in Best-corrected Distance LogMAR Visual Acuity",
                    "description": "Visual acuity measured using the EDTRS visual acuity chart",
                    "timeFrame": "Day 0 through Week 48"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have an area of the central 5 mm zone of cornea affected, presence of at least one clinical sign observed by slit-lamp examination with white light and/or cobalt blue light, fluorescein, and a Wratten filter, and at least one clinical sign observed with AS-OCT.\n* If dosing with Acthar at time of Screening Visit, must have a history of stable dosing for approximately 8 weeks, plan to maintain the same Acthar treatment dose and regimen, and have demonstrated little to no improvement in severity of LSCD.\n* Sponsor written confirmation of qualifying LSCD diagnosis.\n* Inflammation associated with LSCD or other non-infectious inflammation that will not interfere with subject's participation.\n\nExclusion Criteria:\n\n* Any active ocular infection (bacterial, viral, fungal, or protozoan) in either eye.\n* Ocular surgery within 30 days of Day 0 where investigator assesses that healing is not considered complete/stable.\n* Planned ocular surgery on or before Week 20 visit.\n* Presence or history of any ocular or systemic disorder, condition, or procedure that might hinder the efficacy of the study treatment or its evaluation, or could interfere with the interpretation of study results, in the opinion of the investigator.\n\nNote: Other inclusion/exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Central Operations Representative",
                    "role": "CONTACT",
                    "phone": "919-354-1299",
                    "email": "clinicaltrials@clarisbio.com"
                }
            ],
            "locations": [
                {
                    "facility": "Midwest Cornea Associates, LLC",
                    "status": "RECRUITING",
                    "city": "Carmel",
                    "state": "Indiana",
                    "zip": "46290",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.97837,
                        "lon": -86.11804
                    }
                },
                {
                    "facility": "Legacy Devers Eye Institute",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Stuart A. Terry, MD PA",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78212",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000092423",
                    "term": "Limbal Stem Cell Deficiency"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003316",
                    "term": "Corneal Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2921",
                    "name": "Limbal Stem Cell Deficiency",
                    "asFound": "Limbal Stem Cell Deficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6539",
                    "name": "Corneal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "asFound": "Anxiety",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11900",
                    "name": "Mitogens",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}